The Paris System for urinary cytology

The Paris System for urinary cytology

The primary purpose of urinary cytology is to detect high-grade urothelial carcinoma (HGUC).

The Paris System working group, consisting of cytopathologists, anatomo-pathologists and urologists proposed and published a standardized reporting system that includes specific diagnostic categories and cytomorphological criteria for a reliable HCUG diagnosis.

The Paris System for Reporting Urinary Cytology (TPS) was first published in 2016 with the clear goal of standardizing cytologic diagnostic criteria and providing uniform reporting in order to improve patient classification and associated clinical management.

Since the introduction of TPS, there is an improvement in the screening potential and surveillance of urinary cytology, with a reduction in the high rates of unknow diagnoses, improving sensitivity and providing a proper risk classification for patients.

The Paris System diagnostic categories for Urinary Cytology reporting are:

  1. Non-diagnostic/inadequate
  2. Negative for High Grade Uroterial Carcinoma (NHGUC)
  3. Atypical Urothelial Cells (AUC)
  4. Suspect of High Grade Urothelial Carcinoma (SHGUC)
  5. High Grade Urothelial Carcinoma (HGUC)
  6. Low Grade Urothelial Neoplasia (LGUN)
  7. Other: primary and secondary malignancies and various lesions
The parameters that define adequacy in urinary cytology are the cellularity and the volume of urine submitted for analysis; 30 ml appears to be a reasonable volume to minimize the number of inadequate samples and identify high-grade urothelial carcinoma (HGUC).
Bibliography
  • Barkan GA, Wojcik EM, Nayar R, Savic-Prince S, Quek ML, Kurtycz DF, Rosenthal DL. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. Adv Anat Pathol. 2016 Jul;23(4):193-201. doi: 10.1097/PAP.0000000000000118. PMID: 27233050.
  • Pastorello RG, Barkan GA, Saieg M. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature. J Am Soc Cytopathol. 2021 Jan-Feb;10(1):79-87. doi: 10.1016/j.jasc.2020.10.002. Epub 2020 Oct 10. PMID: 33160893.
  • VandenBussche CJ, Rosenthal DL, Olson MT. Adequacy in voided urine cytology specimens: The role of volume and a repeat void upon predictive values for high-grade urothelial carcinoma. Cancer Cytopathol. 2016 Mar;124(3):174-80. doi: 10.1002/cncy.21634. Epub 2015 Nov 2. PMID: 26524350.
The primary purpose of urinary cytology is to detect high-grade urothelial carcinoma (HGUC).

Based on this, the working group The Paris System consisting of cytopathologists, anatomic pathologists, and urologists proposed and published a standardized reporting system that includes specific diagnostic categories and cytomorphological criteria for reliable diagnosis of HGUC.

The Paris System for Reporting Urinary Cytology (TPS) was first published in 2016 with the clear goal of standardizing cytologic diagnostic criteria and providing uniform reporting in order to improve patient classification and associated clinical management.

Since the introduction of TPS, there is an improvement in the screening potential and surveillance of urinary cytology, with a reduction in the high rates of indeterminate diagnoses, improving sensitivity, and providing proper risk classification for patients.

The Paris System diagnostic categories for Urinary Cytology reporting are:

  1. Non-diagnostic/indaquate
  2. Negative for High Grade Uroterial Carcinoma (NHGUC)
  3. Atypical Urothelial Cells (AUC)
  4. Suspicion of High Grade Urothelial Carcinoma (SHGUC)
  5. High Grade Urothelial Carcinoma (HGUC)
  6. Low Grade Urothelial Neoplasia (LGUN)
  7. Other: primary and secondary malignancies and various lesions
The parameters that define adequacy in urinary cytology are cellularity and volume of urine submitted for analysis; 30 ml appears to be a reasonable volume to minimize the number of inadequate samples and identify high-grade urothelial carcinoma (HGUC).
Bibliography
  • Barkan GA, Wojcik EM, Nayar R, Savic-Prince S, Quek ML, Kurtycz DF, Rosenthal DL. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. Adv Anat Pathol. 2016 Jul;23(4):193-201. doi: 10.1097/PAP.0000000000000118. PMID: 27233050.
  • Pastorello RG, Barkan GA, Saieg M. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature. J Am Soc Cytopathol. 2021 Jan-Feb;10(1):79-87. doi: 10.1016/j.jasc.2020.10.002. Epub 2020 Oct 10. PMID: 33160893.
  • VandenBussche CJ, Rosenthal DL, Olson MT. Adequacy in voided urine cytology specimens: The role of volume and a repeat void upon predictive values for high-grade urothelial carcinoma. Cancer Cytopathol. 2016 Mar;124(3):174-80. doi: 10.1002/cncy.21634. Epub 2015 Nov 2. PMID: 26524350.

Request information

Call us at our references. We will be happy to give you all the information about how to partecipate, in person or online.
Location
Auxologico San Luca

Call us

+39 0245898529

Email

info@urinarycytologycongress.org

Request information

Call us at our references. We will be happy to give you all the information about how to partecipate, in person or online.
Location
Auxologico San Luca

Call us

+39 0245898529

Email

info@urinarycytologycongress.org

Organized by:

With the unconditional support of:

Loghi Footer Loght
Location

Auxologico San Luca
Address: Piazzale Brescia 20, Milano
Telephone num.: +39 02619112501

Organizational secretariat

GLOBAL STUDIO
Via E. De Amicis 42, 20123 Milano – Italy
Phone: +39 0245898529
E-mail: info@urinarycytologycongress.org
Booking: global-studio.it

Urinary Cytology Congress 2022 logo
21st May 2022, Milan
Auxologico San Luca

WITH THE UNCONDITIONAL SUPPORT OF:
Main Sponsor

WITH THE UNCONDITIONAL SUPPORT OF:

Co-Sponsor

Loghi Footer Loght
Location

Auxologico San Luca
Address: Piazzale Brescia 20, Milano
Telephone num.: +39 02619112501

Organizational secretariat

Phone: +39 0245898529
Email: info@urinarycytologycongress.org
Booking: global-studio.it

https://urinarycytologycongress.org/wp-content/uploads/2022/02/Urinary-Cytology-Congress-2022-logo-160x160.png

Urinary Cytology Congress

Privacy Policy